“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of cost, will treat patients instead of preventing the disease in the general ...

More and more countries are legalising voluntary assisted dying. But who is accessing it? The results of a recent ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

AstraZeneca and Merck report Lynparza's significant survival benefits in high-risk breast cancer and Keytruda combo results ...

Despite recent events, I believe we have reason to be hopeful, but I fully understand the bitterness that got us here. That’s ...

Johnson & Johnson has received coal in its stocking from the FDA as manufacturing issues have tripped up the company’s ...

Indian tabla maestro Zakir Hussain 73 passes away due to complications from idiopathic pulmonary fibrosis IPF Learn how this ...

China National Medical Products Administration (NMPA) has approved MSD’s KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).

The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D ...

“We believe that together we can approach the problem of improving patient survival in ... The Alliance’s goal is to eliminate lung cancer as a cause of death – the first step towards ...